Litcius/Paper detail

A Fbxo48 inhibitor prevents pAMPKα degradation and ameliorates insulin resistance

Yuan Liu, Michael J. Jurczak, Travis Lear, Bo Lin, Mads Larsen, Jason R. Kennerdell, Yanwen Chen, Brydie R. Huckestein, Matthew K. Nguyen, Ferhan Tuncer, Yu Jiang, Satdarshan P. Monga, Christopher P. O’Donnell, Toren Finkel, Bill B. Chen, Rama K. Mallampalli

2021Nature Chemical Biology35 citationsDOIOpen Access PDF

Topics & Concepts

AMPKAMP-activated protein kinaseAutophagyUbiquitin ligaseProtein kinase AChemistryCell biologyPhosphorylationSignal transductionInsulin resistanceUbiquitinBiologyPharmacologyInsulinEndocrinologyBiochemistryGeneApoptosisAutophagy in Disease and TherapyUbiquitin and proteasome pathwaysMetabolism, Diabetes, and Cancer
A Fbxo48 inhibitor prevents pAMPKα degradation and ameliorates insulin resistance | Litcius